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Association of Marek’s Disease with Ea-B and Immune Response Genes in 
Subline and F2 Populations of the Iowa State S1 Leghorn Line 
Abstract 
Chickens from the Iowa State S1 White Leghorn line, selected for characteristics of Ea-B serotype, 
humoral immune response to glutamic acid-alanine-tyrosine (Ir-GAT), and response to Rous sarcoma 
virus (RSV)-induced tumors, were evaluated for genetic resistance to Marek’s disease (MD). In the first 
two trials, sublines that were triple homozygous for the three traits were challenged with MD virus. Birds 
of the B1B1 blood type were significantly (P<.001) more resistant to MD than chickens of the B19B19 
blood type. High responders to GAT were significantly (P<.001) more resistant to MD virus than low 
responders. The RSV classification had no detectable association with MD resistance. Chickens 
challenged with MD virus in the third trial were an F2 population produced from inter se matings of S1 
chickens heterozygous for the three traits under selection. Data from this trial confirmed increased MD 
resistance of chickens possessing the B1B1 blood type when associated with genes encoding high 
immune response to GAT. 
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BREEDING AND GENETICS 
Association of Marek's Disease with Ea-B and Immune Response 
Genes in Subline and F2 Populations of the 
Iowa State SI Leghorn Line1 
E. M. STEADHAM, S. J. LAMONT,2 I. KUJDYCH,3 
and A. W. NORDSKOG 
Department of Animal Science, Iowa State University, 
Ames, Iowa 50011 
(Received for publication October 11,1985) 
ABSTRACT Chickens from the Iowa State SI White Leghorn line, selected for characteristics of Ea-B 
serotype, humoral immune response to glutamic acid-alanine-tyrosine (Ir-GAT), and response to Rous 
sarcoma virus (RSV)-induced tumors, were evaluated for genetic resistance to Marek's disease (MD). In 
the first two trials, sublines that were triple homozygous for the three traits were challenged with MD virus. 
Birds of the B'B' blood type were significantly (P< .001) more resistant to MD than chickens of the BI9B'9 
blood type. High responders to GAT were significantly (P<.001) more resistant to MD virus than low 
responders. The RSV classification had no detectable association with MD resistance. Chickens challenged 
with MD virus in the third trial were an F2 population produced from inter se matings of SI chickens 
heterozygous for the three traits under selection. Data from this trial confirmed increased MD resistance of 
chickens possessing the B'B' blood type when associated with genes encoding high immune response to GAT. 
(Key words: Marek's disease, major histocompatibility complex, immune response, genetic resistance, 
glutamic acid-alanine-tyrosine) 
1987 Poultry Science 66:571-575 
INTRODUCTION 
The effectiveness of selection for Marek's 
disease (MD) resistance in poultry is well estab-
lished. Pioneering work of Hutt and Cole (1948) 
first established the feasibility of such selection. 
Later work by Cole (1968) demonstrated signif-
icant differences in MD susceptibility after only 
two generations of selection, suggesting simple 
genetic control. Hanson et al. (1967) first re-
ported an association between a B locus blood 
group allele and MD resistance. Cole's MD-re-
sistant line N was found to be uniformly 
homozygous for the B2' allele (Pazderka et al., 
1975; Briles et al., 1977). Other researchers 
have also identified B locus alleles associated 
with MD resistance or susceptiblity (Pazderka 
et al., 1975; Longenecker et al., 1976; Bacon 
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States Regional Poultry Breeding Project, NE-60. Supported 
in part by National Institutes of Health Grant Al 12746. 
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'Present address: Cook College, Poultry Health Labora-
tory, Rutgers, The State University of New Jersey, Vine-
land, NJ 08360. 
and Witter, 1980; Longenecker and Mosmann, 
1981). 
The B complex is the chicken major his-
tocompatibility complex (MHC) for which the 
erythrocyte alloantigen B (Ea-B) serves as a use-
ful genetic marker (Schierman and Nordskog, 
1961). Pevzner et al., (1981) reported that MD 
resistance was associated with the immune re-
sponse region identified by humoral immune 
response to glutamic acid-alanine-tyrosine (Ir-
GAT) within the MHC of the Iowa State Univer-
sity SI line. Briles et al. (1983) and Plachy et 
al. (1984) mapped a gene-controlling MD resis-
tance to the B-F region of the MHC. The B-F 
region, by Plachy's definition, contains the im-
mune response region (B-L); this finding is simi-
lar to those of Pevzner et al. (1981). Briles and 
coworkers (1983), mapping MD resistance by 
using recombinants between the B-F and B-G 
regions, did not comment on linkage of the B-L 
and B-F regions in their crossover. 
Only one generation of SI line chickens 
segregating for both Ea-B and Ir-GAT was chal-
lenged with MD virus in the study of Pevzner 
et al. (1981). Selection for the ability to regress 
Rous sarcoma virus (RSV)-induced tumors has 
also been conducted in the S1 sublines and was 
not addressed in Pevzner's work. The present 
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study reports further analysis of MD susceptibil-
ity in the Iowa State S1 Leghorn line with special 
reference to the association with Ea-B, Ir-GAT, 
and RSV-tumor response. 
MATERIALS AND METHODS 
Genetic Stocks. The SI line originated from 
a cross of two commercial inbred lines 
(Nordskog etal., 1973). It has been maintained 
since 1978 in sublines selected for homozygous 
Ea-B serotype {B'B' or B,9B19) and for humoral 
immune response (high or low) to the amino 
acid polymer GAT (Pevzner et al., 1978). More 
recently, sublines were further selected for resis-
tance or susceptibility to RSV-induced tumors 
from information on sibling tests. This study 
used eight sublines, representing all triple 
homozygous combinations of Ea-B (B1 orB), 
Ir-GAT (high or low), and RSV response (re-
gressor or progressor). Each generation was pro-
duced from five males of each subline which 
were each mated by artificial insemination to 
four or five nonsib hens of the same subline. 
Breeders were selected to represent the appropri-
ate Ea-B and RSV type, and possess optimum 
response to GAT (either high or low, as appro-
priate). Ten to 20% of the progeny in each gen-
eration were selected as breeders. The inbreed-
ing coefficients of Trial 2 sublines averaged 40% 
(Cheng et al., 1985). 
The first two trials used two subsequent gen-
erations of the eight sublines described previ-
ously. The third trial of SI chickens used an F? 
population that was derived from matings of B 
Ir-GAT high/B; Ir-GAT low x B19 Ir-GAT 
high/B' Ir-GAT low and B19 Ir-GAT low/fl7 
Ir-GAT high X B19 Ir-GAT low/S7 Ir-GAT high 
matings (Figure 1). No RSV designation was 
assigned to the chickens of this population, since 
three different genotypes could be generated 
from each mating. Two of the six haplotypes 
produced were phenotypically identical (B B19 
Ir-GAT high), since high response to GAT is a 
dominant trait. In some birds, however, the Ir-
GAT high gene was linked with B19, and in 
others Ir-GAT high was linked with Bl. Data 
from the phenotypically identical groups were 
pooled because the incidences of MD among 
them were not significantly different. This 
yielded five genetic groups for analysis. 
Challenge with Marek's Disease. Challenge 
tests for MD were carried out at the Rutgers 
Poultry Health Laboratory under the supervision 
of I. Kujdych. Two-day old chicks were inocu-
lated intraperitoneally with .25 ml (2,500 pfu) 
of the JM isolate of MD virus (provided by R. 
Witter, Regional Poultry Research Laboratory, 
East Lansing, MI). Chicks were housed together 
in a floor pen and received feed and water ad 
libitum. All birds were necropsied for evidence 
of gross MD lesions at death or at the termination 
of the studies at 17 weeks. 
Chickens in this study were classified as sus-
ceptible to MD if they either died from MD 
before 17 weeks or survived to the termination 
of the experiment and showed MD lesions upon 
necropsy. Analysis of variance was performed 
using percentage susceptible to MD within each 
group as the variable and traits of selection as 









FIG. 1. Pedigree (without inclusion of Rous sarcoma virus classification) of the populations challenged with Marek's 
disease (MD) virus. The H and L represent immune response to glutamic acid-alanine-tyrosine (Ir-GAT) (high and low, 
respectively). Chickens representative of the sublines of the P, generation were challenged in the first two trials. The 
heterozygous chickens (F|) were not challenged with MD virus. The numbers of chicks of the F2 population challenged 
in the third trial are given. The F2 haplotypes within the box were phenotypically identical (B'B
19 Ir-GAT High). 
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sources of variation. Significance of differences 
between genetic groups were tested with the X2 
statistic. 
RESULTS AND DISCUSSION 
Results from Trials 1 and 2 are reported indi-
vidually and are also shown pooled because the 
differences between these trials were not signif-
icant (Tables 1 and 2). The effects of Ea-B, 
Ir-GAT, and their interaction were highly signif-
icant sources of variation in Trials 1 and 2 (Table 
1). Classification for RSV response had no effect 
on MD susceptibility, and is not included in the 
data presented in Table 2. The B'B' Ir-GAT 
high sublines were the most resistant to MD 
(Table 2 and Figure 2). Association of Ir-GAT 
high with resistance to MD in the SI line was 
earlier reported by Pevzner et al. (1981). The 
finding of association of MD resistance with the 
B-FIB-L subregion of the MHC is also congruent 
with findings of Briles et al. (1983) and Plachy 
etal. (1984). 
In this first investigation of association be-
tween RSV response and MD resistance in the 
SI line, chickens differing in RSV classification 
(progressor or regressor) did not differ in inci-
dence of MD (Table 1 and Figure 2). Direct 
selection for RSV response seemed not to influ-
ence MD resistance, even though both are virally 
induced tumors. Calnek et al. (1975) also re-
ported that incidence of MD and susceptibility 
to progressive RSV-induced tumors were not 
necessarily correlated. 
In Trial 3, a challenge of F2 birds, the B'B' 
Ir-GAT high group was significantly different 
from all the other groups in incidence of MD 
(Table 2 and Figure 3). Analysis of variance by 
haplotype showed that genetic group (combina-
tion of Ea-B genotype and Ir-GAT phenotype) 
was a significant source of variation in incidence 
of MD (Table 3). Analysis of the Ea-B x Ir-
GAT interaction could not be carried out in Trial 
3, as it had been in Trials 1 and 2, because of 
the heterozygous individuals tested in Trial 3. 
Data from all three trials show that B'B' Ir-
GAT high chickens are more resistant to MD 
than either B,9B'9 or Ir-GAT low chickens. 
These results are congruent with those of Pevz-
ner et al. (1981). The relatively greater resis-
tance of the B'B' Ir-GAT high haplotype to MD 
compared with other haplotypes has persisted 
for several generations in the SI population. 
Trial 3 of this experiment extends results of 
Pevzner et al. (1981) by testing an F2 population 
and definitively linking resistance to MD with 
genes controlling immune response to GAT. 
The difference in relative resistance to MD 
of the B'B' Ir-GAT low birds between the sub-
lines of Trials 1 and 2 and the F2 population of 
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2Ea-B = Erythrocyte alloantigen B. 
3 Ir-GAT = Immune response to glutamic acid-alanine-tyrosine. 
4 RSV = Rous sarcoma virus. 
5Tested individually, pooled for clarity. 
*P<.01. 
**P<.001. 
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TABLE 2. Incidence ofMarek's disease (MD+) in the SI line1 
Ir-GAT2 
B Genotype Phenotype3 
Trial 1 
Number 
at risk % MD+ 
Trial 2 
Pooled data, 
Trials 1 & 2 Trial 3 
Number Number Number 













































Groups within a column with different superscripts are significantly different in incidence of MD (P<.05). 
'Rous sarcoma virus classification had no effect and is ignored for presentation of genetic group means. 
2Ir-GAT = Immune response to glutamic acid-alanine-tyrosine. 
3 Ir-GAT High dominant over Ir-GAT Low. 
"Includes B' Ir-GAT High/B19 Ir-GAT Low and B1 Ir-GAT Low/B19 Ir-GAT High genotypes. 
Trial 3 suggests a role for complementary gene 
loci outside of the MHC. Fredericksen et al. 
(1977) reported two non-MHC loci that code 
for lymphocyte alloantigens that influence MD 
resistance. Possibly the generation of an F2 
population from the homozygous sublines re-
sulted in a reassortment of complementary loci. 
Future MD challenge of congenic lines of chick-
ens with the SI MHC haplotypes-lines that are 
currently in development-should help to clarify 







































FIG. 2. Incidence of Marek's disease (MD) in SI line 
chickens challenged with JM strain MD virus. Pooled results 
from Trials 1 and 2. Eight sublines are represented, based 
on erythrocyte alloantigen B (Ea-B), immune response to 
glutamic acid-alanine-tyrosine (Ir-GAT), and Rous sarcoma 
virus (RSV) response (regressor or progressor). 
FIG. 3. Incidence of Marek's disease (MD) in SI line 
F2 chickens (erythrocyte alloantigen B (Ea-B) and immune 
response to glutamic acid-alanine-tyrosine (Ir-GAT)), Trial 
3. Five groups are represented as described in Materials and 
Methods. The B'B Ir-GAT High represents the pooled 
results of two haplotypes. 
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TABLE 3. Analysis of variance of factors affecting 
the incidence of Marek's disease: Trial 3l 
Source of 






1 Mean square. 
2 Ea-B = Erythrocyte alloantigen B. 
3 Ir-GAT = immune response to glutamic acid-
alanine-tyrosine. Ea-B and Ir-GAT classifications 
are combined as one factor for analysis (see Materials 
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